Subcutaneous (SubQ) Injection
Also known as: SubQ · SC injection · subcutaneous injection
Injection into the fatty layer immediately beneath the skin and above muscle tissue.
SubQ is the default administration route for most research peptides. The fatty subcutaneous layer absorbs peptides at a predictable, moderate rate — faster than oral (if it worked) and slower than intravenous or intramuscular. Standard SubQ injection sites include the abdomen (avoiding a 2-inch circle around the navel), outer thigh, and back of upper arm.
A 5/16 inch insulin needle angled 45–90 degrees is the established technique. Pinching a skin fold before injection ensures the needle lands in fat rather than muscle for leaner researchers. Aspiration (pulling back on the plunger to check for blood) is not required for SubQ injection per current best-practice guidance.
Related Terms
Intramuscular (IM) Injection
Injection directly into muscle tissue, typically using a longer needle than subcutaneous injection.
Injection Site Rotation
The practice of varying injection location across sessions to prevent tissue irritation, lipohypertrophy, and absorption inconsistency.
Insulin Syringe
A small-gauge, low-volume syringe (typically 29–31 gauge, 0.3–1mL capacity) calibrated in insulin units for subcutaneous injection.
Subcutaneous Absorption Rate
The speed at which a peptide injected into subcutaneous tissue reaches systemic circulation.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial